Label-free Femtosecond Laser Imaging Combined With the Fast Lung Artificial Intelligence Model for Rapid Intraoperative Diagnosis of Lung Surgical Specimens: A Multicentre, Prospective, Parallel-workflow, Non-inferiority Study.

ConditionLung Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorShanghai Chest Hospital

About this trial

This study aims to evaluate whether femtosecond laser imaging combined with FastLung AI model can provide intraoperative diagnostic performance that is non-inferior to standard frozen section diagnosis for pulmonary nodules or suspected pulmonary tumor lesions. Patients scheduled for lung surgery and requiring intraoperative pathological assessment will be prospectively enrolled. After tumor excision, the fresh tumor specimen will be bisected through the central plane. One half will be used for standard frozen section diagnosis, and the mirrored counterpart will be used for femtosecond laser imaging. Both diagnostic results will be compared with the final paraffin-embedded pathological diagnosis as the reference standard. The results of femtosecond laser imaging will not guide intraoperative clinical decision-making.

Eligibility criteria

Qualifiers

Preoperative imaging suggests a pulmonary nodule, pulmonary space-occupying lesion, or suspected pulmonary tumor lesion.

The participant is scheduled to undergo pulmonary wedge resection, segmentectomy, lobectomy, or other pulmonary surgery.

Fresh lung tissue specimens can be obtained intraoperatively for femtosecond laser imaging.

Intraoperative frozen section diagnosis is planned to assess the nature of the tumor lesion.

Disqualifiers

The intraoperative specimen is insufficient and cannot simultaneously meet the requirements for routine clinical pathological diagnosis and research-related testing.

The specimen shows severe carbonization, necrosis, compression, contamination, or improper preservation, and the investigator determines that effective imaging cannot be completed.

The femtosecond laser imaging specimen cannot be matched with the corresponding lesion assessed by final paraffin pathology.

Final paraffin-embedded pathological diagnosis cannot be obtained.

Trial design

Treatments tested in this trial

  • Femtosecond Laser Imaging
  • Frozen Section Diagnosis

Treatment groups

294 Participants
are divided into 1 treatment group

Sponsors and collaborators

Shanghai Chest Hospital

Lead sponsor

Femtosecond Applications and Research (Guangzhou)

Collaborator